European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.69% to 1,924.81 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and petroleum refiner Equinor (EQNR), which climbed 6.8% and 4.9%, respectively. They were followed by semiconductor company Sequans Communications (SQNS) and brewing company Anheuser-Busch InBev (BUD), which advanced 4% and 2.8%, respectively.
The decliners from continental Europe were led by internet browser company Opera (OPRA) and biopharmaceutical company DBV Technologies (DBVT), which dropped 3.3% and 2.9%, respectively. They were followed by telecommunications company Nokia (NOK) and software firm SAP (SAP), which lost 2.6% and 2%, respectively.
The gainers from the UK were led by biopharmaceutical firm Akari Therapeutics (AKTX) and insurance firm Prudential (PUK), which rose 6.6% and 3.4%, respectively. They were followed by lender HSBC (HSBC) and telecommunications company operator Vodafone Group (VOD), which were up 2.2% each.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which shed 21% and 2.8% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and educational publisher Pearson (PSO), which fell 1.2% and 0.8% respectively.
Comments